National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 315150

History of Changes from the VAERS Wayback Machine

First Appeared on 12/8/2009

315150
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 8/31/2010

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 4/13/2011

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 5/13/2011

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 6/11/2011

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 5/13/2013

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
ROTH1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi


Changed on 4/14/2017

315150 Before After
VAERS Form:
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 - / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102 102mg/dl; Body temperature, 13Feb2008, 37.0degC; C-reactive protein, 13Feb2008, 0.2mg/dl; Gamma-glutamyltransferase, 13Feb2008, normal; Hemoglobin, 13Feb2008, normal; Lactate dehydrogenase, 13Feb2008, normal; MCH, 13Feb2008, normal; MCV, 13Feb2008, normal; PCO2, 13 Feb2008, 31.5mmHg; PO2, 13Feb2008, 70.7mmHg; Partial prothrombin time, 13Feb2008, normal; Platelet count, 13Feb2008, normal; Quick''s test, 13Feb2008, normal; Red blood cell count, 13Feb2008, normal; White blood cell count, 13Feb2008, 11.0/nl; pH,
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general conditi condition, experienced no fever (body temperature was 37.0 degC) and showed rosy complexion. Abdominal examination was soft on palpation, showed no pain on pressure and no pathologic resistances. Throat examination was normal. The eardrums were covered with earwax both sides. Lung examination showed vesicular breathing sounds both sides. Heart examination showed clear and rhythmic heart sounds. Laboratory examinations showed C-reactive protein (CRP) of 0.2 mg/dl and white blood cell count of 11.0 /nl. All other laboratory examinations for liver enzymes, blood electrolytes, blood coagulation and blood count were normal. Blood gas analysis showed pH of 7.415, pCO2 of 31.5 mmHg, pO2 of 70.7 mmHg, HCO3 of 19.8 mmol/l, base excess of -3.5 mmol/l, well-balanced electrolytes and blood glucose level of 102 mg/dl. Invagination was confirmed by abdominal sonography. Treatment in hospital included disinvagination by giving an enema with water (pre-warmed NaCl solution). The event resolved without complications. Post disinvagination the subject discharged lots of faeces. Abdominal sonography, performed on 14 February 2008, showed normal intestinal structures except mild oedematous changes, no signs of re-invagination and no ileus. On 14 February 2008, the subject was discharged from hospital in good general condition. No further information will be available. Case D0057465A was identified as a duplicate of case D0056291A and will be voided. All future correspondence will be submitted to the case of Record D0056291A. This subject was enrolled in an epidemiological study to gather epidemiological back-ground data on the incidence of intussusception in foreign country.


Changed on 9/14/2017

315150 Before After
VAERS Form:(blank) 1
Age:0.3
Gender:Female
Location:Foreign
Vaccinated:2008-02-08
Onset:2008-02-12
Submitted:2008-06-05
Entered:2008-06-05
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
RV1: ROTAVIRUS (ROTARIX) / GLAXOSMITHKLINE BIOLOGICALS A41CA385A / 0 1 - MO / PO

Administered by: Other      Purchased by: Other
Symptoms: Alanine aminotransferase normal, Aspartate aminotransferase normal, Blood bicarbonate normal, Blood glucose increased, Blood lactate dehydrogenase normal, Blood pH normal, Body temperature increased, C-reactive protein normal, Gamma-glutamyltransferase normal, Haemoglobin normal, Intussusception, Mean cell haemoglobin normal, Mean cell volume normal, Oedema, Platelet count normal, PO2 increased, Prothrombin time, Prothrombin time normal, Red blood cell count normal, Restlessness, Vomiting, White blood cell count increased, Enema administration, Ultrasound abdomen abnormal, PCO2 normal, Base excess negative, Blood electrolytes normal

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit? (V2.0) No
Hospitalized? Yes, days: 2     Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness: Unknown
Preexisting Conditions:
Allergies:
Diagnostic Lab Data: Alanine aminotransferase, 13Feb2008, normal; Aspartate aminotransferase, 13Feb2008, normal; Base excess, 13Feb2008, -3.5mmol/l; Blood bicarbonate, 13Feb2008, 19.8mmol/l; Blood electrolytes, 13Feb2008, balanced; Blood glucose, 13Feb2008, 102mg/dl; Body temperature, 13Feb2008, 37.0degC; C-reactive protein, 13Feb2008, 0.2mg/dl; Gamma-glutamyltransferase, 13Feb2008, normal; Hemoglobin, 13Feb2008, normal; Lactate dehydrogenase, 13Feb2008, normal; MCH, 13Feb2008, normal; MCV, 13Feb2008, normal; PCO2, 13 Feb2008, 31.5mmHg; PO2, 13Feb2008, 70.7mmHg; Partial prothrombin time, 13Feb2008, normal; Platelet count, 13Feb2008, normal; Quick''s test, 13Feb2008, normal; Red blood cell count, 13Feb2008, normal; White blood cell count, 13Feb2008, 11.0/nl; pH, 13Feb2008, 7.415; Abdominal sonography, performed on 13 February 2008, Intussusception / invagination at the expected site; Abdominal sonography during enema, performed on 13 February 2008, Rectal filling with pre-warmed NaCl solution up to the head of the invagination without problems, invagination was also driven back by Bauhin''s valve, good filling of the terminal ileal loops, Assessment: disinvagination successful; Abdominal sonography, performed on 14 February 2008, Normal abdominal sonography, especially concerning the intestine, intestinal structures normal except mild oedematous changes, no signs of re-invagination, no ileus.
CDC 'Split Type': D0056291A

Write-up:This case was reported by a physician via a sales representative and described the occurrence of invagination of intestine in a 4-month-old female subject who was vaccinated with ROTARIX (GlaxoSmithKline). On 28 February 2008, the same case was reported by via regulatory authority ((vaccines, biologicals) #DE-PEI-PEI2008001865). The subject has no underlying or concurrent medical conditions or other risk factors. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). Approximately five days post vaccination with ROTARIX, on 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised for an unknown period of time. The reporting physician considered that the event was life threatening. Invagination was confirmed by sonography. Treatment in hospital included disinvagination by giving an enema. After about six hours, on 13 February 2008 or 14 February 2008, the event was resolved. The vaccination course with ROTARIX was discontinued. According to the information received by PEI the reporter considered that the event was probably related to vaccination with ROTARIX. Follow-up information was received on 06 March 2008 by the reporting physician including the hospital report. The subject has no underlying or concurrent medical conditions or other risk factors. The subject received no concomitant medication. On 08 February 2008 the subject received the first dose of ROTARIX (1 ml, oral). On 13 February 2008, the subject experienced invagination of intestine. The subject was hospitalised this event for two days. Anamnesis, according to hospital report: On day prior to invagination of intestine, on 12 February 2008, the subject showed increased restlessness. During night from 12 February 2008 to 13 February 2008 the subject experienced a single episode of splash-like vomiting. The subject was examined by the reporting physician and hospitalised. On admission to hospital, on 13 February 2008, the subject was in satisfactory general condition, experienced no fever (body temperature was 37.0 degC) and showed rosy complexion. Abdominal examination was soft on palpation, showed no pain on pressure and no pathologic resistances. Throat examination was normal. The eardrums were covered with earwax both sides. Lung examination showed vesicular breathing sounds both sides. Heart examination showed clear and rhythmic heart sounds. Laboratory examinations showed C-reactive protein (CRP) of 0.2 mg/dl and white blood cell count of 11.0 /nl. All other laboratory examinations for liver enzymes, blood electrolytes, blood coagulation and blood count were normal. Blood gas analysis showed pH of 7.415, pCO2 of 31.5 mmHg, pO2 of 70.7 mmHg, HCO3 of 19.8 mmol/l, base excess of -3.5 mmol/l, well-balanced electrolytes and blood glucose level of 102 mg/dl. Invagination was confirmed by abdominal sonography. Treatment in hospital included disinvagination by giving an enema with water (pre-warmed NaCl solution). The event resolved without complications. Post disinvagination the subject discharged lots of faeces. Abdominal sonography, performed on 14 February 2008, showed normal intestinal structures except mild oedematous changes, no signs of re-invagination and no ileus. On 14 February 2008, the subject was discharged from hospital in good general condition. No further information will be available. Case D0057465A was identified as a duplicate of case D0056291A and will be voided. All future correspondence will be submitted to the case of Record D0056291A. This subject was enrolled in an epidemiological study to gather epidemiological back-ground data on the incidence of intussusception in foreign country.


New Search

Link To This Search Result:

http://www.medalerts.org/vaersdb/findfield.php?IDNUMBER=315150&WAYBACKHISTORY=ON


Copyright © 2018 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166